Second Cancers in a Patient with Gastric MALT Lymphoma

Overview

Journal Case Rep Med

Publisher Wiley

Specialty General Medicine

Date 2020 Jun 9

PMID 32508929

Authors

Lucy Navsaria

Alfonso Badillo

Michael Wang

Affiliations

Soon will be listed here.

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade B-cell lymphoma, which is thought to arise from a background of chronic immune stimulation, bacterial, viral, or autoimmune stimuli. Treatment advances have increased the number of MALT lymphoma survivors, but there is still debate as to whether these patients are at a higher risk of developing second cancers. This is a case of a long-surviving (>20 years) patient with multiple diagnosed malignancies following MALT lymphoma. We describe how modern oncological treatment plans can provide patients with prolonged survival and increased quality of life despite increasing age and multiple malignancies.

References

Boot H, de Jong D . Diagnosis, treatment decisions, and follow up in primary gastric lymphoma. Gut. 2002; 51(5):621-2. PMC: 1773436. DOI: 10.1136/gut.51.5.621. View

Montalban C, Castrillo J, Lopez-Abente G, Abraira V, Serrano M, Bellas C . Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma. 1999; 33(1-2):161-8. DOI: 10.3109/10428199909093738. View

Filip P, Cuciureanu D, Diaconu L, Vladareanu A, Pop C . MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life. 2018; 11(3):187-193. PMC: 6197515. DOI: 10.25122/jml-2018-0035. View

Raderer M, Streubel B, Wohrer S, Hafner M, Chott A . Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut. 2005; 55(5):616-8. PMC: 1856121. DOI: 10.1136/gut.2005.083022. View

Moser E, Noordijk E, van Leeuwen F, Baars J, Thomas J, Carde P . Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study. Haematologica. 2006; 91(11):1481-8. View

Bacon C, Du M, Dogan A . Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J Clin Pathol. 2006; 60(4):361-72. PMC: 2001121. DOI: 10.1136/jcp.2005.031146. View

Nam T, Ahn J, Choi Y, Jeong J, Kim Y, Yoon M . The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Res Treat. 2014; 46(1):33-40. PMC: 3918525. DOI: 10.4143/crt.2014.46.1.33. View

Zucca E, Bertoni F . The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood. 2016; 127(17):2082-92. DOI: 10.1182/blood-2015-12-624304. View

Ruskone-Fourmestraux A, Lavergne A, Aegerter P, Megraud F, Palazzo L, de Mascarel A . Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 2001; 48(3):297-303. PMC: 1760135. DOI: 10.1136/gut.48.3.297. View

10.

Ruskone-Fourmestraux A, Fischbach W, Aleman B, Boot H, Du M, Megraud F . EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011; 60(6):747-58. DOI: 10.1136/gut.2010.224949. View

11.

Travis L, Gospodarowicz M, Curtis R, Clarke E, Andersson M, Glimelius B . Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst. 2002; 94(3):182-92. DOI: 10.1093/jnci/94.3.182. View

12.

Stolte M, Bayerdorffer E, Morgner A, Alpen B, Wundisch T, Thiede C . Helicobacter and gastric MALT lymphoma. Gut. 2002; 50 Suppl 3:III19-24. PMC: 1867678. DOI: 10.1136/gut.50.suppl_3.iii19. View

13.

Novak U, Basso K, Pasqualucci L, Dalla-Favera R, Bhagat G . Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells. Br J Haematol. 2011; 155(3):362-5. DOI: 10.1111/j.1365-2141.2011.08841.x. View

14.

Zinzani P . The many faces of marginal zone lymphoma. Hematology Am Soc Hematol Educ Program. 2012; 2012:426-32. DOI: 10.1182/asheducation-2012.1.426. View

15.

Raderer M, Kiesewetter B, Ferreri A . Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin. 2016; 66(2):153-71. DOI: 10.3322/caac.21330. View

16.

Goteri G, Ranaldi R, Rezai B, Baccarini M, Bearzi I . Synchronous mucosa-associated lymphoid tissue lymphoma and adenocarcinoma of the stomach. Am J Surg Pathol. 1997; 21(5):505-9. DOI: 10.1097/00000478-199705000-00001. View

17.

Zorlu A, Atahan I, Gedikoglu G, Ruacan S, Sayek I, Tekuzman G . Does gastric adenocarcinoma develop after the treatment of gastric lymphoma?. J Surg Oncol. 1993; 54(2):126-31. DOI: 10.1002/jso.2930540214. View

18.

Zucca E, Pinotti G, Roggero E, Comi M, Pascarella A, Capella C . High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol. 1995; 6(7):726-8. DOI: 10.1093/oxfordjournals.annonc.a059292. View

19.

Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S . Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. Ann Oncol. 2011; 22(8):1845-58. DOI: 10.1093/annonc/mdq697. View

20.

Steinbach G, Ford R, Glober G, Sample D, Hagemeister F, Lynch P . Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999; 131(2):88-95. DOI: 10.7326/0003-4819-131-2-199907200-00003. View